Data / Form D filings / NEPHRX CORP
NEPHRX CORP: Form D filing
NEPHRX CORP, a biotechnology company in Kalamazoo, MI, filed a Form D with the SEC in 2010. The latest, on February 10, 2010, reports $6.2 million sold of a $6.2 million offering to 12 investors.
Find out what NEPHRX CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4717 CAMPUS DRIVE, Kalamazoo, MI, 49008
- Phone
- (248) 838-4785
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506, Investment Company Act section 3(c), section 3(c)(1)
- SEC identifier (CIK)
- 1171421
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2010 | Amendment | $6,219,317 | $6,219,317 | $0 | 12 | Nov 15, 2007 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elizabeth Long | Executive Officer | |
| William McGinnis | Executive Officer | |
| Douglas Morton | Director | |
| Patrick Morand | Director | |
| Thomas Cox | Director | |
| Charles Hall | Director | |
| James Koziarz | Director | |
| Phillip Long | Director | |
| Donald Parfet | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Feb 8, 2010 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEPHRX CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.